Clinical Trials Directory

Trials / Completed

CompletedNCT00000284

Role of Metabolites in Nicotine Dependence (1) - 1

Role of Metabolites in Nicotine Dependence (1)

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
0 (planned)
Sponsor
National Institute on Drug Abuse (NIDA) · NIH
Sex
All
Age
21 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the effects of cotinine with or without a transdermal nicotine replacement on tobacco withdrawal symptoms.

Detailed description

The purpose of this study was to determine the effects of a metabolite of nicotine, cotinine, on tobacco withdrawal symptoms. Cotinine has been shown to have psychoactive effects that are similar as well as different from those of nicotine, however, little research has been conducted examining the role cotinine plays in nicotine addiction. This study compared the effects of cotinine with the nicotine patch, and a combination thereof on tobacco withdrawal symptoms. The results showed that cotinine antagonizes the beneficial effects of the nicotine patch in reducing withdrawal symptoms.

Conditions

Interventions

TypeNameDescription
DRUGCotinine fumarate

Timeline

Start date
1995-02-01
Completion
2001-12-01
First posted
1999-09-21
Last updated
2017-01-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00000284. Inclusion in this directory is not an endorsement.

Role of Metabolites in Nicotine Dependence (1) - 1 (NCT00000284) · Clinical Trials Directory